Professional Documents
Culture Documents
Kefir & Cancer - Irian Review - PDF Versión 1
Kefir & Cancer - Irian Review - PDF Versión 1
HÀUDQG&DQFHU
Systematic Review
.H¿UDQG&DQFHU$6\VWHPDWLF5HYLHZRI/LWHUDWXUHV
1DKLG5D¿H06F1,2, Sahar Golpour Hamedani MSc1,2, Reza Ghiasvand PhD1,2, Maryam Miraghajani PhD candidate1,2
Abstract
6RPHVWXGLHVKDYHVXJJHVWHGFKHPRSUHYHQWLYHHIIHFWVRINH¿UDIHUPHQWHGPLONSURGXFWRQFDUFLQRJHQHVLV7KHDLPRIWKLVUHYLHZVWXG\
ZDVWRHYDOXDWHWKHVFLHQWL¿FHYLGHQFHIRUHIIHFWVRINH¿URQFDQFHUSUHYHQWLRQDQGWUHDWPHQW:HV\VWHPDWLFDOO\VHDUFKHGIRUDOOUHOHYDQW
VWXGLHVSXEOLVKHGEHIRUH-XQHXVLQJ3XE0HG*RRJOHVFKRODU&RFKUDQHDQG6FLHQFH'LUHFW6,'0HG/LEDQG6UOVWGDWDEDVHV5HO-
HYDQWVWXGLHVZHUHUHYLHZHGEDVHGRQV\VWHPDWLFUHYLHZ35,60$JXLGHOLQHV)URPDWRWDORISDSHUVREWDLQHGDWWKHLQLWLDOGDWDEDVH
search, 11 publications including 7in vitro and 4 experimental studies were eligible. In vitro studies on breast, colon, skin and gastric cancers
DQGOHXNHPLDFHOOOLQHVDQGH[SHULPHQWDOVWXGLHVRQGLIIHUHQWVDUFRPDVFRQVLVWHQWO\VKRZHGEHQH¿FLDOHIIHFWVRINH¿URQFDQFHUSUHYHQWLRQ
DQGWUHDWPHQW7KHUHVXOWVRIWKLVV\VWHPDWLFUHYLHZVXJJHVWWKDWNH¿UPD\EHDVVRFLDWHGZLWKFDQFHUSUHYHQWLRQDQGLWDOVRKDVEHQH¿FLDO
HIIHFWVLQFDQFHUWUHDWPHQW7KLVSURWHFWLRQPD\EHDVVRFLDWHGZLWKNH¿UELRDFWLYHFRPSRQHQWVLQFOXGLQJSHSWLGHVSRO\VDFFKDULGHVDQG
sphingolipids.
Keywords:&DQFHUIHUPHQWHGPLONSURGXFWVNH¿UV\VWHPDWLFUHYLHZ
Introduction WKHUHVXOWVREWDLQHGIURPVWXGLHVRQWKHHIIHFWVRINH¿UDQGNH¿U
products on tumor prevention and treatment. So, we come to a
C
ancer, abnormal division and reproduction of cells that can conclusion regarding potential properties of this beverage in some
spread throughout the body,1 is a leading cause of death cancer prevention and treatment programs.
worldwide and the total number of cases is increasing
globally.2 A recent analysis estimated 13.2 million deaths and 20.3 Materials and Methods
million incident cases for cancer in 2030.3 Thus preventive strate-
gies are critical in every cancer control plan.2 Among factors re- This systematic review methodology was performed based on
sponsible for cancer, it has been estimated that diet accounts for the Preferred Reporting Item for Systematic Review and Meta-
about 20%–30% of all cases worldwide. Several studies support analysis (PRISMA) statement recommendation and all steps were
the idea that some dietary components, such as fruits and vegeta- reviewed independently by two investigators.
bles, are protective factors against cancer.4 There is also evidence
that a diet rich in fermented foods such as fermented milk prod- Search strategy
XFWVPD\KDYHEHQH¿FLDOSURSHUWLHVLQUHGXFLQJULVNRIVRPHFDQ- We searched the PubMed, Google scholar, Cochrane, Science
cers.5–7.H¿ULVDW\SHRIIHUPHQWHGPLONPDGHIURPDGGLQJVPDOO Direct, EBSCO, MedLib, Srlst and SID databases for studies
FDXOLÀRZHUÀRUHWOLNHJUDLQVWRSDVWHXUL]HGPLON7KHJUDLQVFRQ- SXEOLVKHGXSWR-XQHXVLQJWKHVHDUFKWHUPV³NH¿U>WLDEV@
tain a mixture of yeast and bacteria living in a symbiotic commu- OR, “cultured milk products” [tiabs] OR “fermented milk prod-
QLW\ 7KLV VSHFLDO V\PELRWLF QDWXUH PDNHV NH¿U GLIIHUHQW IURP ucts” [tiabs]) AND (“cancer” [tiabs] OR “neoplasm” [tiabs] OR
other fermented dairy products such as yogurt. The alleged healthy “neoplasms” [tiabs] OR “tumors” [tiabs]) to identify studies in-
FDSDELOLWLHV RI NH¿U LQFOXGH DQWLIXQJDO DQG DQWLEDFWHULDO SURSHU- YHVWLJDWLQJWKHHIIHFWVRINH¿URQFDQFHUSUHYHQWLRQDQGWUHDWPHQW
WLHVEHQH¿WVIRUGLJHVWLYHWUDFWDQGEHQH¿FLDOHIIHFWVRQFKROHV- No restrictions were imposed. We also did a manual search on
WHURO,WKDVDOVREHHQIRXQGWRH[HUWEHQH¿FLDOHIIHFWVRQSUHYHQW- reference lists of retrieved relevant articles for additional primary
ing several types of cancer.8$QWLFDQFHUSURSHUWLHVRINH¿UKDYH studies.
been linked to the presence of a number of bioactive components
including peptides, polysaccharides9 and sphingolipids which Eligibility criteria
KDYHVLJQL¿FDQWUROHVLQVHYHUDOW\SHVRIVLJQDOLQJSDWKZD\VDQG We included studies in this review if they were conducted on the
regulation of some cellular processes including cell proliferation, HIIHFWVRINH¿URQFDQFHUSUHYHQWLRQDQGWUHDWPHQW7KHH[FOXVLRQ
apoptosis and transformation.10 criteria were: 1) papers in which the main treatment or exposure
The present systematic review was conducted to summarize ZDVQRWNH¿USDSHUVLQYHVWLJDWLQJFRQGLWLRQVRWKHUWKDQFDQFHU
SDSHUVZLWKQRUHSRUWRQWKHHIIHFWVRINH¿URQFDQFHUSUHYHQ-
$XWKRUV¶ DI¿OLDWLRQV 1Food Security Research Center, Isfahan University of tion and treatment, 4) papers not published in English or Persian.
Medical Sciences, Isfahan, Iran. 2Department of Community Nutrition, School of
Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
&RUUHVSRQGLQJDXWKRUDQGUHSULQWVMaryam Miraghajani PhD, Department
Study selection
of Community Nutrition, School of Nutrition and Food Science Isfahan Uni- %ULHÀ\ SDSHUV ZHUH LGHQWL¿HG WKURXJK WKH V\VWHPDWLF
versity of Medical Sciences, Isfahan, Iran. Tel: +98-31-36688487, Fax: +98-31- VHDUFK,QWKH¿UVWVWDJHDQLQLWLDOVFUHHQRILGHQWL¿HGDEVWUDFWV
36682509, E-mail: ms.miraghajani@yahoo.com
Accepted for publication: 9 September 2015
or titles was established and 158 irrelevant papers were excluded.
852 Archives of Iranian Medicine, Volume 18, Number 12, December 2015
15DÀH6*ROSRXU+DPHGDQL5*KLDVYDQGHWDO
For the next stage, 25 papers were screened based on full-text of man mammary cancer cells compared to normal human mamma-
DUWLFOHVWRLQFOXGHVWXGLHVUHSRUWLQJHIIHFWVRINH¿URQFDQFHU3D- ry epithelial cells at different doses which were expressed based
pers were excluded if they were irrelevant according to the exclu- RQFHOOQXPEHUV)RXUNH¿USURGXFWVZHUHXVHGLQWKLVVWXG\.B
VLRQFULWHULD)LQDOO\DWRWDORISDSHUVZHUHLGHQWL¿HGDVHOLJLEOH .0LONZDVLQFXEDWHGZLWKNH¿UJUDLQV.DQGIHUPHQWHGIRU
IRUWKLVV\VWHPDWLFUHYLHZ$ÀRZFKDUWVKRZLQJWKHVWXG\VHOHF- 24 hr to prepare the mother culture (K2). The resulting mother
tion process is presented in Figure 1. culture was added (1%–3%) to pasteurized milk (K3) and by fer-
PHQWLQJWKLVSURGXFWIRUDSSUR[LPDWHO\KRXUWKH¿QDOSURG-
Data extraction uct (K4) was prepared. A pasteurized milk sample and different
The information extracted from the included articles is as fol- yogurt extracts were used for comparison. After 6 days of cell
ORZV QDPH RI WKH ¿UVW DXWKRU SXEOLFDWLRQ \HDU FXOWXUH PHGLD FXOWXUHZLWKNH¿USURGXFWVWKHIHUPHQWHGPRWKHUFXOWXUH.DQG
model animal, type of treatment, dose of treatment, duration, WKH¿QDONH¿USURGXFW.VKRZHGVLJQL¿FDQWP < 0.01) dose-
events followed, observed effects and P value. The characteristics dependent suppressive effects on malignant cells proliferation
of the selected studies are presented in Table 1. with no inhibitory effects on normal cells. In comparison to the
controls, the malignant cells treated with K1 product showed sig-
Results QL¿FDQWJURZWKDWDOOGRVHVDERYH7KH.SURGXFWVKRZHG
no effect on malignant cell proliferation relative to controls. As
Among 11 eligible articles, 7 and 4 studies were performed us- NH¿UH[WUDFWVXVHGLQWKLVVWXG\ZHUHSURGXFHGZLWKGLIIHUHQWGH-
ing in vitro human cancer cell lines and in vivo animal models, JUHHVRIIHUPHQWDWLRQWKH\SRVVLEO\FRQWDLQHGGLIIHUHQWSUR¿OHVRI
respectively. Considering the main aspects of the total included bioactive components including peptides which could explain the
papers and based on the location of the cancer, the results were differences observed between products.
as follows: Another study by de Moreno de Leblanc, et al.11 in 2010 studied
WKHHIIHFWVRIRUGD\VRIF\FOLFDOFRQVXPSWLRQRINH¿UDQGD
Breast cancer NH¿UFHOOIUHHIUDFWLRQ.)SUHSDUHGE\FHQWULIXJLQJNH¿UDW&
7ZR VWXGLHV ZHUH IRXQG WKDW H[DPLQHG WKH HIIHFWV RI NH¿U RQ for 20 min and then drying and refrigerating the resultant superna-
breast cancer cells.9,11 7KH ¿UVW VWXG\ E\ &KXMLDQ &KHQ et al.9 tant until tested, on hormone dependent breast cancer prevention
evaluated in vitro DQWLSUROLIHUDWLYHHIIHFWVRINH¿UH[WUDFWVRQKX- in mice. In four groups of mice, after 2 or 7 consecutive days of
x Data on fermented
products other than
kefir
Records screened
(n = 183) Records excluded
(n = 158)
Figure1.6WXG\ÀRZGLDJUDPRIWKHVHDUFKSURFHVV
Archives of Iranian Medicine, Volume 18, Number 12, December 2015 853
Table 1. Characteristics of the included articles.
Human colon
Reduced DNA damage
Grishina14, 2009 In vitro adenocarcinoma .H¿UVXSHUQDWDQW 20, 50, 100, 200μL/mL 30 min DNA damage
( P < 0.001)
cells
Dose dependent anti proliferative
Human gastric
JieGao17, 2013 In vitro cell free fraction of TK 0, 2, 4, 6, 8, 10 mg/mL 24 hours Cell proliferation effects
cancer cell line
( P < 0.05)
Human melanoma Suppression of DNA damage
Tsutomu Nagira18, 2002 In vitro $TXHRXVH[WUDFWRINH¿U 9.6 mg/mL 5 hours DNA damage
cells ( P < 0.05)
Reduced proliferation/ proapoptotic
Human leukemia Cell proliferation/
Katia Maalouf12, 2011 In vitro &HOOIUHHIUDFWLRQRINH¿U 0, 20, 40, 60, 80 mg/mL 6, 24 and 48 hours effects/ little cytotoxicity
cell line cytotoxicity / apoptosis
( P < 0.05)
Reduced proliferation/ proapoptotic
Human leukemia Cell proliferation/
Sandra Rizk13, 2009 In vitro &HOOIUHHIUDFWLRQRINH¿U 0, 20, 40, 60, 80 mg/mL 6, 24 and 48 hours effects/ little cytotoxicity
cell line cytotoxicity / apoptosis
( P < 0.05)
5%
854 Archives of Iranian Medicine, Volume 18, Number 12, December 2015
Human colorectal 24hr
10% Cell proliferation/ Reduced proliferation/ proapoptotic
Nathalie Khoury15, 2014 In vitro adenocarcinoma &HOOIUHHIUDFWLRQRINH¿U 48hr
15% apoptosis effects ( P < 0.05)
cell lines 72hr
20%
Oral administration of
Sarcoma tumor 0- 30 days after Inhibition of tumor growth
Je- Ruei Liu20, 2009 Experimental PLONDQGVR\PLONNH¿UVRU 5 mL Tumor growth
cells administration ( P < 0.05)
distilled water
Archives of Iranian Medicine, Volume 18, Number 12, December 2015 855
.HÀUDQG&DQFHU
856 Archives of Iranian Medicine, Volume 18, Number 12, December 2015
15DÀH6*ROSRXU+DPHGDQL5*KLDVYDQGHWDO
3): 125 – 137 tial anticarcinogenic peptides from bovine milk. J Amino Acids. 2013;
19. Cevikbas A, Yemni E, Ezzedenn FW, Yardimici T, Cevikbas U, Stohs 2013.
6$QWLWXPRXUDODQWLEDFWHULDODQGDQWLIXQJDODFWLYLWLHVRINH¿UDQGNH- 23. Murofushi M, Mizuguchi J, Aibara K, Matuhasi T. Immunopotentia-
¿UJUDLQPhytother Res. 1994; 8(2): 78 – 82. WLYHHIIHFWRISRO\VDFFKDULGHIURPNH¿UJUDLQ.*)&DGPLQLVWHUHG
20. /LX-5:DQJ6</LQ<</LQ&:$QWLWXPRUDFWLYLW\RIPLONNH¿U orally in mice. Immunopharmacology. 1986; 12(1): 29 – 35.
DQGVR\PLONNH¿ULQWXPRUEHDULQJPLFHNutr Cancer. 2002; 44(2): 24. Osada K, Nagira K, Teruya K, Tachibana H, Shirahata S, Murakami
183 – 187. H. Enhancement of interferon-beta production with sphingomyelin
21. Shiomi M, Sasaki K, Murofushi M, Aibara K. Antitumor activity in from fermented milk. Biotherapy. 1993; 7(2): 115 – 123.
PLFH RI RUDOO\ DGPLQLVWHUHG SRO\VDFFKDULGH IURP NH¿U JUDLQ Jpn J 25. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic
Med Sci Biol. 1982; 35(2): 75 – 80. health: fermentation and short chain fatty acids.J Clin Gastroenterol.
22. Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P. Poten- 2006; 40(3): 235 – 243.
)DWHK$EDG*DUGHQ.PIURP.HUPDQ,UDQ1RYHPEHU0+$]L]L0'
Archives of Iranian Medicine, Volume 18, Number 12, December 2015 857